Hyperfine, Inc.

HYPR ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $3.9M $3.9M $5.3M $3.4M $2.7M $2.1M $2.3M $3.6M
Cost of Revenue $1.9M $1.9M $2.6M $1.6M $1.4M $1.3M $1.5M $1.7M
Gross Profit $2.0M $2.0M $2.7M $1.8M $1.3M $883.0K $826.0K $1.9M
Gross Margin 50.7% 50.7% 50.9% 53.8% 49.3% 41.3% 35.6% 52.4%
Operating Expenses
Research & Development $3.9M $3.8M $3.8M $4.0M $4.5M $5.0M $5.1M $5.9M
SG&A Expense $3.9M $4.1M $4.0M $4.2M $3.9M $4.2M $4.1M $4.5M
Operating Income $-8.5M $-8.6M $-7.7M $-8.9M $-9.6M $-10.9M $-10.8M $-11.0M
Operating Margin -216.9% -219.3% -144.9% -259.5% -355.9% -510.2% -463.8% -300.9%
Interest Expense — — — — — — — —
Pretax Income $-9.3M $-8.6M $-5.9M $-11.0M $-9.2M $-9.4M $-10.4M $-10.3M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income $-9.3M $-8.6M $-5.9M $-11.0M $-9.2M $-9.4M $-10.4M $-10.3M
Net Margin -238.2% -220.9% -111.7% -320.6% -342.2% -440.7% -447.7% -283.4%
EPS (Basic) $-0.09 $-0.09 $-0.05 $-0.14 $-0.12 $-0.12 $-0.14 $-0.14
EPS (Diluted) $-0.09 $-0.09 $-0.05 $-0.14 $-0.12 $-0.12 $-0.14 $-0.14
Shares Outstanding (Basic) 99.8M 97.7M 81.8M 79.0M 78.1M 75.7M 72.4M 72.7M
Shares Outstanding (Diluted) 99.8M 97.7M 81.8M 79.0M 78.1M 75.7M 72.4M 72.7M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 3 Older →